• 31.10.2007, 09:10:40
  • /
  • OTE0003

Avantium to Deliver Flowrence(TM) Systems to Shell

Amsterdam (ots/PRNewswire) - Avantium Technologies announced today
that they have signed an agreement with CRI/Criterion Inc. to enable
the sale and delivery of multiple Avantium Flowrence(TM) systems.

CRI/Criterion, a catalyst technology company within the Royal
Dutch Shell group, is a part of a group of affiliated companies that
are leading providers of catalysts, process technologies and catalyst
services for a wide range of chemical and refinery applications.
Under the agreement Avantium will sell and deliver Flowrence(TM)
Research platforms to CRI/Criterion or its affiliates to enhance its
research capabilities.

Tom van Aken, Chief Executive Officer of Avantium:" We are pleased
to provide our unique Flowrence(TM) technology to Shell. The sale of
Flowrence(TM) platforms to a world leading company such as Shell is a
recognition of the value of our proprietary high-throughput R&D
technology. These systems allow our customers to significantly
increase their R&D productivity."

Flowrence(TM) is a proprietary system developed by Avantium for
catalysis research. It consists of a parallel fixed bed reactor
system with 16 reactors suited for gas and liquid phase, as well as
trickle flow operation. Flowrence(TM) enables users to test catalytic
materials for a range of chemistries under industrial processing
conditions, including high-temperature and high-pressure reactions.

Profile Avantium

Avantium is a leading technology company in the area of advanced
high-throughput R&D operating in the energy, chemicals and
pharmaceutical industries. The company develops products and
processes in the area of biofuels, bio-based chemicals and novel
crystal forms of existing drugs by applying its proprietary,
high-throughput R&D technology. Avantium has demonstrated the
potential of this technology by providing R&D services and tools to
more than 70 companies worldwide, including many of the world's
largest energy, chemicals and pharmaceutical companies. Avantium has
approximately 100 employees; its offices and head quarters are based
in Amsterdam, the Netherlands.

Flowrence(TM)

For more information about Flowrence(TM), including downloads and
pictures, please visit http://www.flowrence.com or
http://www.avantium.com. Flowrence(TM) is a trademark of Avantium
Technologies B.V.

Visit Avantium's corporate website at: http://www.avantium.com

Other Information

This release may contain certain forward-looking statements
relating to the business, financial performance and results of
Avantium and the industry in which it operates. These statements are
based on its current plans, estimates and projections, as well as its
expectations of external conditions and events. A number of important
factors, and the inherent risks and uncertainties that such
statements involve, could cause actual results or outcomes to differ
materially from those expressed in any forward-looking statements.

In the event of any inconsistency between an English version and a
Dutch version of this document, the English version will prevail over
the Dutch version.

Rückfragehinweis:
For more information about this press release please contact us via:
Citigate First Financial, Jose Tijssen / Claire Verhagen, Phone:
+31-20-575-4010, Email: [email protected] /
[email protected]

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | PRN

Bei Facebook teilen.
Bei X teilen.
Bei LinkedIn teilen.
Bei Xing teilen.
Bei Bluesky teilen

Stichworte

Channel